PubMed for Bookshelf ID: 4860552

Year	Number of Results
2014	2
2015	1
2016	4
2017	3
2019	4
2024	0

1

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Mar 11;61(1567):33-37. Med Lett Drugs Ther. 2019. PMID: 30845096 No abstract available.

2

Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study.

Dalbeth N, Jones G, Terkeltaub R, Khanna D, Fung M, Baumgartner S, Perez-Ruiz F. Dalbeth N, et al. Arthritis Res Ther. 2019 Jan 7;21(1):8. doi: 10.1186/s13075-018-1788-4. Arthritis Res Ther. 2019. PMID: 30616614 Free PMC article. Clinical Trial.

3

Potential Dangers of Serum Urate-Lowering Therapy.

Perez-Gomez MV, Bartsch LA, Castillo-Rodriguez E, Fernandez-Prado R, Kanbay M, Ortiz A. Perez-Gomez MV, et al. Am J Med. 2019 Apr;132(4):457-467. doi: 10.1016/j.amjmed.2018.12.010. Epub 2019 Jan 3. Am J Med. 2019. PMID: 30611833 Review.

4

Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout.

Terkeltaub R, Saag KG, Goldfarb DS, Baumgartner S, Schechter BM, Valiyil R, Jalal D, Pillinger M, White WB. Terkeltaub R, et al. Rheumatology (Oxford). 2019 Jan 1;58(1):61-69. doi: 10.1093/rheumatology/key245. Rheumatology (Oxford). 2019. PMID: 30124941 Free PMC article.

5

Lesinurad/allopurinol (Duzallo) for gout-associated hyperuricemia.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2017 Nov 6;59(1533):182-183. Med Lett Drugs Ther. 2017. PMID: 29125593 No abstract available.

6

Lesinurad (Zurampic) for gout-associated hyperuricemia.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2016 Nov 21;58(1508):148-150. Med Lett Drugs Ther. 2016. PMID: 27849193 Review. No abstract available.

7

Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study).

Bardin T, Keenan RT, Khanna PP, Kopicko J, Fung M, Bhakta N, Adler S, Storgard C, Baumgartner S, So A. Bardin T, et al. Ann Rheum Dis. 2017 May;76(5):811-820. doi: 10.1136/annrheumdis-2016-209213. Epub 2016 Nov 7. Ann Rheum Dis. 2017. PMID: 27821644 Free PMC article. Clinical Trial.

8

Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).

Saag KG, Fitz-Patrick D, Kopicko J, Fung M, Bhakta N, Adler S, Storgard C, Baumgartner S, Becker MA. Saag KG, et al. Arthritis Rheumatol. 2017 Jan;69(1):203-212. doi: 10.1002/art.39840. Arthritis Rheumatol. 2017. PMID: 27564409 Clinical Trial.

9

Lesinurad: First Global Approval.

Hoy SM. Hoy SM. Drugs. 2016 Mar;76(4):509-16. doi: 10.1007/s40265-016-0550-y. Drugs. 2016. PMID: 26861027 Review.

10

Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol.

Perez-Ruiz F, Sundy JS, Miner JN, Cravets M, Storgard C; RDEA594-203 Study Group. Perez-Ruiz F, et al. Ann Rheum Dis. 2016 Jun;75(6):1074-80. doi: 10.1136/annrheumdis-2015-207919. Epub 2016 Jan 7. Ann Rheum Dis. 2016. PMID: 26742777 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year